SCHEMBL9004142

SCHEMBL9004142

CCC(/C=C/c1ccc(Cl)cc1)=N\OCCN(CC)CC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.42
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TRPA1 O75762 1/20 0.40
ACHE P22303 4/20 0.39
MAOB P27338 3/20 0.39
BCHE P06276 2/20 0.39
EBP Q15125 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
CYP1A2 P05177 2/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9412227 0.90 KCNH2 (0.43) KCNH2MAPTMEN1KMT2ATRPA1
SCHEMBL9004149 0.90 KCNH2 (0.43) KCNH2MAPTMEN1KMT2ATRPA1
SCHEMBL9004100 0.88 HTR2A (0.46) MAPTMEN1KMT2ATRPA1ACHE
SCHEMBL9004076 0.86 MCHR1 (0.46) ACHEMAOBBCHELMNASMN1; SMN2
SCHEMBL9004096 0.86 ACHE (0.38) KCNH2MAPTMEN1KMT2AACHE
SCHEMBL9004122 0.79 HTR2A (0.45) KCNH2MAPTMEN1KMT2ATRPA1
SCHEMBL9004115 0.79 HTR2A (0.45) KCNH2MAPTMEN1KMT2ATRPA1
SCHEMBL9004121 0.79 HTR2A (0.45) KCNH2MAPTMEN1KMT2ATRPA1
SCHEMBL9004105 0.77 BCHE (0.49) MEN1KMT2ATRPA1ACHEBCHE
SCHEMBL9004102 0.75 HTR2A (0.51) TRPA1ACHEMAOBBCHEHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5486528-A ANTIULCER AGENTS, ANXIOLYTIC AGENTS EGIS GYOGYSZERGYAR RT. (HU) 1996-01-23 US disclosed
EP-0619299-A2 1-(Phenyl)-3-[omega-(amino)-alkoxyimino]-alk-1-ene derivatives, a process for preparing them as well as medicaments containing them and the use of them EGIS GYOGYSZERGYAR RT. (HU) 1994-10-12 EP disclosed